Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Privia Health Group, Inc. (PRVA) Market Cap & Valuation Ratios

Privia Health Group, Inc. (PRVA) has a market cap of $2.9B, a trailing P/E of 106.7 and a price-to-sales ratio of 1.2, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PRVAPrivia Health Group, Inc.Follow PRVA — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
2.9B
P/E TTM
106.7
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Peers

health information services · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
PRVA2.9106.71.043.04.6%+24%2%8%
HNGE9.086.412.087.53.2%+50%13%158%
HQY8.637.56.818.25.1%+7%26%10%
DOCS6.039.38.727.34.9%+11%30%19%
WAY5.541.25.615.74.5%+19%23%4%
HTFL4.9—22.5—-1.2%+43%-38%-33%
OMCL1.7—1.311.97.4%+8%5%3%
CERT1.6—4.122.33.5%+0.7%-0.2%-0.1%
OMDA1.2—3.0172.81.5%+48%-0.1%-1%
TDOC1.2—0.67.711.4%-2%-8%-11%
HSTM1.048.83.013.74.0%+9%8%7%
Median of these 1041.24.918.24.2%+10%6%4%

P/E 106.7 vs. a peer median of 41.2; EV/Sales 1.0 vs. 4.9. PRVA's own P/E sits at the 33rd percentile of its history.

Growth vs. price

each dot a company · hover or tap for values
501000%+10%+20%+30%+40%+50%revenue growth, TTM →P/E (log)PRVAHNGEHQYDOCSWAYHSTM

HTFL and OMCL and CERT and OMDA and TDOC have no P/E (earnings not positive) and are left out · hover or tap a dot for values.

Privia Health Group, Inc. — questions

What is Privia Health Group, Inc.'s market cap?
$2.9B.
What is Privia Health Group, Inc.'s P/E ratio?
106.7 on trailing twelve-month earnings to 2026-06-30.
What is Privia Health Group, Inc.'s price-to-sales ratio?
1.2.

Every figure on this page comes from Privia Health Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.